Treatment of inclusion-body myositis with IVIg: A double-blind, placebo-controlled study

Article abstract-We randomized 19 patients with inclusion-body myositis (IBM) to a double-blind, placebo-controlled, crossover study using monthly infusions of 2 g/kg intravenous immunoglobulin (IVIg) or placebo for 3 months. Patients crossed over to the alternate treatment after a washout period. W...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurology 1997-03, Vol.48 (3), p.712-716
Hauptverfasser:	Dalakas, M C, Sonies, B, Dambrosia, J, Sekul, E, Cupler, E, Sivakumar, K
Format:	Artikel
Sprache:	eng
Schlagworte:	Activities of Daily Living Adult Aged Amyloid - analysis Biological and medical sciences Biopsy Deglutition - physiology Double-Blind Method Follow-Up Studies Humans Immunoglobulins, Intravenous - therapeutic use Immunomodulators Medical sciences Middle Aged Muscle, Skeletal - pathology Muscle, Skeletal - physiopathology Myositis, Inclusion Body - pathology Myositis, Inclusion Body - physiopathology Myositis, Inclusion Body - therapy Pharmacology. Drug treatments Quality of Life Retrospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!